Second Ashland weight loss clinic accused of administering non-FDA approved drugs. Mary Jane Epling, The Daily Independent, Ashland, Ky. Sun, May 25, 2025 at 3:59 AM UTC. 4 min read.

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx ...

Please provide your email address to receive an email when new articles are posted on . Large-data AI models may also be used to identify non-FDA-approved drugs for Parkinson’s disease. There is ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...

Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug. Jan. 31, 2025 ... Despite excellent execution of its clinical strategy over the past several months and two new drugs approved, ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical organizations to speak out about safety concerns.In December, the FDA ...

A San Francisco physician has agreed to pay more than $1 million to resolve allegations that he charged Medicare for non-FDA-approved drugs and associated services. The U.S. Justice Department ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Key Takeaways. U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults ...

After the FDA’s approval, suzetrigine became the first new painkiller approved in the US in 27 years. Journavx was evaluated in two randomized controlled trials of acute surgical pain.